Current role of LC-MS(/MS) in doping control

Analytical and Bioanalytical Chemistry

Volumn 401, Issue 2, 2011, Pages 405-420

  Thevis, Mario ^a   Thomas, Andreas ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Doping control; High resolution; Mass spectrometry; Retrospective analysis; Screening; Sport

Indexed keywords

CONFIRMATION METHODS; DETECTION METHODS; DOPING CONTROL; DRUG TESTING; EXTRACTED ION CHROMATOGRAM; HIGH RESOLUTION; INTEGRAL PART; ION PAIRS; LONG-TERM PERSPECTIVE; LOW RESOLUTION; PRE-SELECTED; PROTONATED; RETROSPECTIVE ANALYSIS; SCAN MODE; SCREENING PROCEDURES; SPORT; TARGET ANALYTES;

CHROMATOGRAPHIC ANALYSIS; GAS CHROMATOGRAPHY; IONS; LIQUID CHROMATOGRAPHY;

MASS SPECTROMETRY;

ANABOLIC AGENT; PERFORMANCE ENHANCING SUBSTANCE;

DOPING; HUMAN; LIQUID CHROMATOGRAPHY; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY;

ANABOLIC AGENTS; CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; HUMANS; PERFORMANCE-ENHANCING SUBSTANCES; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 79960556066     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-4859-9     Document Type: Review

References (92)

1. M Thevis W Schänzer 2005 Mass spectrometry in doping control analysis Curr Org Chem 9 825 848 10.2174/1385272054038318 1:CAS:528: DC%2BD2MXkvFCmt7s%3D (Pubitemid 40753867)
2. P Hemmersbach 2008 History of mass spectrometry at the olympic games J Mass Spectrom 43 839 853 10.1002/jms.1445 1:CAS:528:DC%2BD1cXptVehurw%3D (Pubitemid 352035817)
3. Thevis M (2010) Mass spectrometry in sports drug testing - characterization of prohibited substances and doping control analytical assays. Wiley, Hoboken
4. M Thevis W Schänzer 2007 Current role of LC-MS(/MS) in doping control Anal Bioanal Chem 388 1351 1358 10.1007/s00216-007-1131-4 1:CAS:528:DC%2BD2sXnsVeqtr8%3D (Pubitemid 47150865)
5. Donike M, Geyer H, Gotzmann A, Kraft M, Mandel F, Nolteernsting E, Opfermann G, Sigmund G, Schänzer W, Zimmermann J (1987) In: Bellotti P, Benzi G, Ljungqvist A (eds) International Athletic Foundation - world symposium on doping in sport. Arti Grafiche Danesi, Florence, pp 53-80
6. R Ventura M Roig N Montfort P Saez R Berges J Segura 2008 High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents Eur J Mass Spectrom (Chichester, Eng) 14 191 200 10.1255/ejms.920 1:CAS:528:DC%2BD1cXhtVegsbjF
7. World Anti-Doping Agency (2010) Minimum required performance levels for detection of prohibited substances. http://www.wada-ama.org/Documents/World- Anti-Doping-Program/WADP-IS-Laboratories/WADA-TD2010MRPLv1.0- Minimum%20Required%20Performance%20Levels-Sept%2001%202010-EN.pdf. Accessed 26 Oct 2010
8. JO Thörngren F Östervall M Garle 2008 A high-throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS J Mass Spectrom 43 980 992 10.1002/jms.1436 (Pubitemid 352029667)
9. M Mazzarino X de la Torre F Botre 2008 A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS/MS Anal Bioanal Chem 392 681 698 10.1007/s00216-008-2292-5 1:CAS:528:DC%2BD1cXhtFOru7vN
10. M Mazzarino S Riggi X de la Torre F Botre 2010 Speeding up the process urine sample pre-treatment: some perspectives on the use of microwave assisted extraction in the anti-doping field Talanta 81 1264 1272 10.1016/j.talanta.2010. 02.019 1:CAS:528:DC%2BC3cXlsFGmu7Y%3D
11. M Mazzarino X de la Torre F Botre N Gray D Cowan 2010 A rapid screening LC-MS/MS method based on conventional HPLC pumps for the analysis of low molecular weight xenobiotics: application to doping control analysis Drug Test Anal 2 311 322 10.1002/dta.148 1:CAS:528:DC%2BC3cXhtFKltrnM
12. M Thevis S Beuck A Thomas B Kortner M Kohler G Rodchenkov W Schänzer 2009 Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503 Rapid Commun Mass Spectrom 23 1139 1146 10.1002/rcm.3987 1:CAS:528:DC%2BD1MXksFajsbk%3D
13. World Anti-Doping Agency (2011) The 2011 prohibited list. http://www.wada-ama.org/Documents/World-Anti-Doping-Program/WADP-Prohibited- list/To-be-effective/WADA-Prohibited-List-2011-EN.pdf. Accessed 27 Oct 2010
14. World Anti-Doping Agency (2009) The world anti-doping code - international standard for laboratories. http://www.wada-ama.org/rtecontent/ document/International-Standard-for-Laboratories-v6-0-January-2009.pdf. Accessed 24 Nov 2008
15. ED Virus TG Sobolevsky GM Rodchenkov 2008 Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control J Mass Spectrom 43 949 957 10.1002/jms.1447 1:CAS:528:DC%2BD1cXptVehu7w%3D (Pubitemid 352029663)
16. M Kolmonen A Leinonen T Kuuranne A Pelander I Ojanperä 2009 Generic sample preparation and dual polarity liquid chromatography - time-of-flight mass spectrometry for high-throughput screening in doping analysis Drug Test Anal 1 250 266 10.1002/dta.50 1:CAS:528:DC%2BD1MXht1Gnur3I
17. RJ Peters JE Oosterink AA Stolker C Georgakopoulos MW Nielen 2010 Generic sample preparation combined with high-resolution liquid chromatography-time-of- flight mass spectrometry for unification of urine screening in doping-control laboratories Anal Bioanal Chem 396 2583 2598 10.1007/s00216-010-3484-3 1:CAS:528:DC%2BC3cXhvFGnu7k%3D
18. A Vonaparti E Lyris YS Angelis I Panderi M Koupparis A Tsantili-Kakoulidou RJ Peters MW Nielen C Georgakopoulos 2010 Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry Rapid Commun Mass Spectrom 24 1595 1609 10.1002/rcm.4554 1:CAS:528:DC%2BC3cXmt12ls74%3D
19. F Badoud E Grata L Perrenoud L Avois M Saugy S Rudaz JL Veuthey 2009 Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis J Chromatogr A 1216 4423 4433 10.1016/j.chroma.2009.03.033 1:CAS:528: DC%2BD1MXltFWnsr8%3D
20. F Badoud E Grata L Perrenoud M Saugy S Rudaz JL Veuthey 2010 Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis J Chromatogr A 1217 4109 4119 10.1016/j.chroma.2009.11.001 1:CAS:528:DC%2BC3cXmvVWju7w%3D
21. A Thomas S Guddat M Kohler O Krug W Schänzer M Petrou M Thevis 2010 Comprehensive plasma-screening for known and unknown substances in doping controls Rapid Commun Mass Spectrom 24 1124 1132 10.1002/rcm.4492 1:CAS:528:DC%2BC3cXjvVejt78%3D
22. M Thevis AA Makarov S Horning W Schänzer 2005 Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyzers Rapid Commun Mass Spectrom 19 3369 3378 10.1002/rcm.2204 1:CAS:528:DC%2BD2MXht1Ogtb3E (Pubitemid 41682068)
23. M Thevis G Fuhöller H Geyer U Mareck G Sigmund A Koch A Thomas W Schänzer 2006 Detection of stanozolol and its major metabolites in human urine by liquid chromatography-tandem mass spectrometry Chromatographia 64 441 446 10.1365/s10337-006-0043-3 1:CAS:528:DC%2BD2sXhslKitLs%3D (Pubitemid 44521407)
24. K Deventer PV Eenoo FT Delbeke 2006 Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry Biomed Chromatogr 20 429 433 10.1002/bmc.579 1:CAS:528:DC%2BD28XltF2gtL0%3D
25. S Ahi A Beotra S Jain 2009 Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons Drug Test Anal 1 538 544 10.1002/dta.76 1:CAS:528:DC%2BC3cXhtl2hsrg%3D
26. M Thevis S Guddat W Schanzer 2009 Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry Steroids 74 315 321 10.1016/j.steroids.2008.10.004 1:CAS:528: DC%2BD1MXivVensr4%3D
27. DH Catlin MH Sekera BD Ahrens B Starcevic Y-C Chang CK Hatton 2004 Tetrahydrogestrinone: discovery, synthesis, and detection in urine Rapid Commun Mass Spectrom 18 1245 1249 10.1002/rcm.1495 1:CAS:528:DC%2BD2cXlt1KlsLs%3D (Pubitemid 38843145)
28. OJ Pozo P Van Eenoo K Deventer FT Delbeke 2007 Development and validation of a qualitative screening method for the detection of exogenous anabolic steroids in urine by liquid chromatography-tandem mass spectrometry Anal Bioanal Chem 389 1209 1224 10.1007/s00216-007-1530-6 1:CAS:528:DC%2BD2sXhtVyntbfM (Pubitemid 47482268)
29. M Thevis G Opfermann U Bommerich W Schänzer 2005 Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry J Mass Spectrom 40 494 502 10.1002/jms.820 1:CAS:528:DC%2BD2MXktFKjur4%3D (Pubitemid 40637873)
30. M Thevis W Schänzer 2005 Mass spectrometric analysis of androstan-17beta-ol-3-one and androstadiene-17beta-ol-3-one isomers J Am Soc Mass Spectrom 16 1660 1669 10.1016/j.jasms.2005.06.007 1:CAS:528: DC%2BD2MXhtVamsrzE (Pubitemid 41345158)
31. OJ Pozo P Van Eenoo K Deventer S Grimalt JV Sancho F Hernandez FT Delbeke 2008 Collision-induced dissociation of 3-keto anabolic steroids and related compounds after electrospray ionization. Considerations for structural elucidation Rapid Commun Mass Spectrom 22 4009 4024 10.1002/rcm.3823 1:CAS:528:DC%2BD1MXnsFOguw%3D%3D
32. M Thevis H Geyer U Mareck W Schänzer 2005 Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry J Mass Spectrom 40 955 962 10.1002/jms.873 1:CAS:528: DC%2BD2MXnvF2ltLw%3D (Pubitemid 41098082)
33. OJ Pozo K Deventer PV Eenoo FT Delbeke 2008 Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry Anal Chem 80 1709 1720 10.1021/ac7020757 1:CAS:528:DC%2BD1cXhtVaitro%3D (Pubitemid 351429577)
34. L Hintikka T Kuuranne A Leinonen M Thevis W Schanzer J Halket D Cowan J Grosse P Hemmersbach MW Nielen R Kostiainen 2008 Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison J Mass Spectrom 43 965 973 10.1002/jms.1434 1:CAS:528:DC%2BD1cXptVehu7o%3D (Pubitemid 352029665)
35. E Strahm N Baume P Mangin M Saugy C Ayotte C Saudan 2009 Profiling of 19-norandrosterone sulfate and glucuronide in human urine: implications in athlete's drug testing Steroids 74 359 364 10.1016/j.steroids.2008.11.005 1:CAS:528:DC%2BD1MXivVensrg%3D
36. E Strahm S Rudaz JL Veuthey M Saugy C Saudan 2008 Profiling of 19-norsteroid sulfoconjugates in human urine by liquid chromatography mass spectrometry Anal Chim Acta 613 228 237 10.1016/j.aca.2008.02.053 1:CAS:528:DC%2BD1cXktl2rsLc%3D
37. M Thevis M Kohler J Maurer N Schlörer M Kamber W Schänzer 2007 Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis Rapid Commun Mass Spectrom 21 3477 3486 10.1002/rcm.3247 1:CAS:528:DC%2BD2sXht12jtL%2FN (Pubitemid 350033328)
38. M Thevis M Kohler N Schlörer M Kamber A Kuhn MW Linscheid W Schänzer 2008 Mass spectrometry of hydantoin-derived selective androgen receptor modulators J Mass Spectrom 43 639 650 10.1002/jms.1364 1:CAS:528:DC%2BD1cXntlWrs74%3D (Pubitemid 351785690)
39. M Thevis M Kohler A Thomas J Maurer N Schlörer M Kamber W Schänzer 2008 Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS Anal Bioanal Chem 391 251 261 10.1007/s00216-008-1882-6 1:CAS:528:DC%2BD1cXkvFClt7s%3D
40. M Thevis M Kohler A Thomas N Schlörer W Schänzer 2008 Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry Rapid Commun Mass Spectrom 22 2471 2478 10.1002/rcm.3637 1:CAS:528:DC%2BD1cXhtVehtbjJ
41. M Thevis W Schänzer 2008 Mass spectrometry of selective androgen receptor modulators J Mass Spectrom 43 865 876 10.1002/jms.1438 1:CAS:528:DC%2BD1cXptVehuro%3D (Pubitemid 352029655)
42. M Thevis M Kamber W Schänzer 2006 Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes Rapid Commun Mass Spectrom 20 870 876 10.1002/rcm.2389 1:CAS:528:DC%2BD28XitlGgsrw%3D (Pubitemid 43326696)
43. Z Wu W Gao MA Phelps D Wu DD Miller JT Dalton 2004 Favorable effects of weak acids on negative-ion electrospray ionization mass spectrometry Anal Chem 76 839 847 10.1021/ac0351670 1:CAS:528:DC%2BD2cXjtFWlsA%3D%3D (Pubitemid 38166594)
44. M Thevis A Thomas W Schänzer 2008 Mass spectrometric determination of insulins and their degradation products in sports drug testing Mass Spectrom Rev 27 35 50 10.1002/mas.20154 1:CAS:528:DC%2BD1cXns1Kisw%3D%3D (Pubitemid 350279865)
45. M Thevis A Thomas W Schänzer 2010 Insulin Handb Exp Pharmacol 195 209 226 10.1007/978-3-540-79088-4-10 1:CAS:528:DC%2BC3cXnvFWnu70%3D
46. A Thomas W Schänzer P Delahaut M Thevis 2009 Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high resolution/high accuracy mass spectrometry Drug Test Anal 1 219 227 10.1002/dta.35 1:CAS:528:DC%2BD1MXhtlahsLrE
47. RI Holt PH Sonksen 2008 Growth hormone, IGF-I and insulin and their abuse in sport Br J Pharmacol 154 542 556 10.1038/bjp.2008.99 1:CAS:528: DC%2BD1cXmt1Kqur4%3D (Pubitemid 351744958)
48. RIG Holt 2009 Detecting growth hormone abuse in athletes Drug Test Anal 1 426 433 10.1002/dta.59 1:CAS:528:DC%2BC3cXnsFWluw%3D%3D
49. RG Kay C Barton CP Velloso PR Brown C Bartlett AJ Blazevich RJ Godfrey G Goldspink R Rees GR Ball DA Cowan SD Harridge J Roberts P Teale CS Creaser 2009 High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration Rapid Commun Mass Spectrom 23 3173 3182 10.1002/rcm.4237 1:CAS:528:DC%2BD1MXhtV2ltb%2FO
50. M Bredehöft W Schänzer M Thevis 2008 Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry Rapid Commun Mass Spectrom 22 477 485 10.1002/rcm.3388 (Pubitemid 351300581)
51. A Thomas M Kohler W Schänzer P Delahaut M Thevis 2011 Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS Analyst 136 1003 1012 10.1039/c0an00632g 10.1039/c0an00632g 1:CAS:528:DC%2BC3MXhvVCrtL4%3D
52. A Thomas M Kohler W Schanzer M Kamber P Delahaut M Thevis 2009 Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry Rapid Commun Mass Spectrom 23 2669 2674 10.1002/rcm.4176 1:CAS:528: DC%2BD1MXpslyqu74%3D
53. A Thomas H Geyer M Kamber W Schänzer M Thevis 2008 Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS J Mass Spectrom 43 908 915 10.1002/jms.1453 1:CAS:528:DC%2BD1cXptVehurY%3D (Pubitemid 352029659)
54. M Okano M Sato A Ikekita S Kageyama 2010 Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry Rapid Commun Mass Spectrom 24 2046 2056 10.1002/rcm.4619 1:CAS:528:DC%2BC3cXnvVOgtLc%3D
55. A Thomas M Kohler J Mester H Geyer W Schänzer M Petrou M Thevis 2010 Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement Drug Test Anal 2 144 148 1:CAS:528:DC%2BC3cXjvFagtLY%3D
56. J Henninge M Pepaj I Hullstein P Hemmersbach 2010 Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation Drug Test Anal 2 647 650 10.1002/dta.233 10.1002/dta.233 1:CAS:528:DC%2BC3MXit1Cruw%3D%3D
57. K Deventer OJ Pozo P Van Eenoo FT Delbeke 2009 Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection J Chromatogr A 1216 5819 5827 10.1016/j.chroma.2009.06.003 1:CAS:528:DC%2BD1MXotl2gtbY%3D
58. S Guddat M Thevis W Schänzer 2008 Identification and quantification of the osmodiuretic mannitol in urine for sports drug testing using gas chromatography-mass spectrometry Eur J Mass Spectrom (Chichester, Eng) 14 127 133 10.1255/ejms.918 1:CAS:528:DC%2BD1cXhtVegsbjO
59. M Thevis J Maurer M Kohler H Geyer W Schänzer 2007 Proteases in doping control analysis Int J Sports Med 28 545 549 10.1055/s-2007-965159 1:CAS:528:DC%2BD2sXpslOrt7Y%3D (Pubitemid 47080133)
60. S Lamon N Robinson PE Sottas H Henry M Kamber P Mangin M Saugy 2007 Possible origins of undetectable EPO in urine samples Clin Chim Acta 385 61 66 10.1016/j.cca.2007.06.018 1:CAS:528:DC%2BD2sXhtVCgsLrE (Pubitemid 47374667)
61. A Thomas M Kohler K Walpurgis W Schänzer M Thevis 2009 Proteolysis and autolysis of proteases and the detection of degradation products in doping control Drug Test Anal 1 81 86 10.1002/dta.20 1:CAS:528:DC%2BD1MXkvFGmtbc%3D
62. M Kohler A Thomas H Geyer L Horta W Schänzer M Thevis 2009 Detection of the protease Bacillolysin in doping-control urine samples Drug Test Anal 1 143 145 10.1002/dta.29 1:CAS:528:DC%2BD1MXhtVyntr%2FN
63. M Thevis I Möller A Thomas S Beuck G Rodchenkov W Bornatsch H Geyer W Schänzer 2010 Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls Anal Bioanal Chem 396 2479 2491 10.1007/s00216-009-3283-x 1:CAS:528:DC%2BD1MXhsVylsLrF
64. A Thomas S Beuck JC Eickhoff S Guddat O Krug M Kamber W Schänzer M Thevis 2010 Quantification of urinary AICAR concentrations as a matter of doping controls Anal Bioanal Chem 396 2899 2908 10.1007/s00216-010-3560-8 1:CAS:528:DC%2BC3cXjtFSmt7Y%3D
65. M Kohler A Thomas K Walpurgis W Schänzer M Thevis 2010 Detection of siRNA from plasma samples by mass spectrometry for doping control purposes Anal Bioanal Chem 398 1305 1312 10.1007/s00216-010-4013-0 1:CAS:528: DC%2BC3cXpt1yisr8%3D
66. M Thevis G Sigmund H Geyer W Schänzer 2010 Stimulants and doping in sport Endocrinol Metab Clin North Am 39 89 105 10.1016/j.ecl.2009.10.011 1:CAS:528:DC%2BC3cXjtFWhu78%3D ix
67. M Donike 2011 The detection of doping by means of chromatographic methods Drug Test Anal 3 15 17 10.1002/dta.238 10.1002/dta.238 1:CAS:528: DC%2BC3MXot1Ohtw%3D%3D
68. A Thomas G Sigmund S Guddat W Schanzer M Thevis 2008 Determination of selected stimulants in urine for sports drug analysis by solid phase extraction via cation exchange and means of liquid chromatography-tandem mass spectrometry Eur J Mass Spectrom (Chichester, Eng) 14 135 143 10.1255/ejms.925 1:CAS:528:DC%2BD1cXhtVegsbjP
69. J Lu S Wang Y Dong X Wang S Yang J Zhang J Deng Y Qin Y Xu M Wu G Ouyang 2010 Simultaneous analysis of fourteen tertiary amine stimulants in human urine for doping control purposes by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry Anal Chim Acta 657 45 52 10.1016/j.aca.2009.10.016 1:CAS:528:DC%2BD1MXhsV2mtrbF
70. SK Lee SH Kim HJ Kim HH Yoo OS Kwon MK In C Jin DH Kim J Lee 2010 Simultaneous qualitative and quantitative method using liquid chromatography selected reaction monitoring-triggered quantitation-enhanced data-dependent tandem mass spectrometry for the identification and classification of amphetamine-type stimulant abusers in human urine Rapid Commun Mass Spectrom 24 3139 3145 10.1002/rcm.4747 1:CAS:528:DC%2BC3cXhsVKktr3P
71. L Perrenoud M Saugy C Saudan 2009 Detection in urine of 4-methyl-2-hexaneamine, a doping agent J Chromatogr B 877 3767 3770 10.1016/j.jchromb.2009.09.013 1:CAS:528:DC%2BD1MXht1Gksb7M
72. M Thevis G Sigmund A Koch S Guddat HH Maurer W Schanzer 2008 Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry Eur J Mass Spectrom (Chichester, Eng) 14 145 152 10.1255/ejms.926 1:CAS:528:DC%2BD1cXhtVegsbjI
73. M Thevis G Sigmund A Thomas V Gougoulidis G Rodchenkov W Schänzer 2009 Doping control analysis of metamfepramone and two major metabolites using liquid chromatography - tandem mass spectrometry Eur J Mass Spectrom 15 507 515 10.1255/ejms.1010 1:CAS:528:DC%2BD1MXnslGns7c%3D
74. M Mazzarino S Turi F Botre 2008 A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography-mass spectrometry based on class-characteristic fragmentation pathways Anal Bioanal Chem 390 1389 1402 10.1007/s00216-007-1802-1 1:CAS:528:DC%2BD1cXisVentb0%3D
75. C Chebbah OJ Pozo K Deventer P Van Eenoo FT Delbeke 2010 Direct quantification of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis Rapid Commun Mass Spectrom 24 1133 1141 10.1002/rcm.4499 1:CAS:528:DC%2BC3cXjvVejt70%3D
76. U Mareck N Haenelt H Geyer S Guddat M Kamber R Brenneisen M Thevis W Schänzer 2009 Temporal indication of cannabis use by means of THC glucuronide determination Drug Test Anal 1 505 510 10.1002/dta.106 1:CAS:528:DC%2BC3cXhtl2iu7o%3D
77. A Wintermeyer I Möller M Thevis M Jübner J Beike MA Rothschild K Bender 2010 In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal Bioanal Chem 398 2141 2153 10.1007/s00216-010-4171-0 1:CAS:528:DC%2BC3cXhtFCqsrbI
78. I Möller A Wintermeyer K Bender M Jübner A Thomas O Krug W Schänzer M Thevis 2011 Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls Drug Test Anal 10.1002/dta.158
79. T Sobolevsky I Prasolov G Rodchenkov 2010 Detection of JWH-018 metabolites in smoking mixture post-administration urine Forensic Sci Int 200 141 147 10.1016/j.forsciint.2010.04.003 1:CAS:528:DC%2BC3cXotVagsbo%3D
80. Beuck S, Möller I, Thomas A, Klose A, Schlörer N, Schänzer W, Thevis M (2011) Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesized reference material for the support of LC-MS/MS-based drug testing. Anal Bioanal Chem. doi: 10.1007/s00216-011-4931-5
81. T Kuuranne A Leinonen W Schänzer M Kamber R Kostiainen M Thevis 2008 Aryl-propionamide-derived selective androgen receptor modulators: LC-MS/MS characterization of the in vitro synthesized metabolites for doping control purposes Drug Metab Dispos 36 571 581 10.1124/dmd.107.017954 1:CAS:528:DC%2BD1cXjt1arsbw%3D (Pubitemid 351397983)
82. M Thevis E Gerace A Thomas S Beuck H Geyer N Schlörer JD Kearbey JT Dalton W Schänzer 2010 Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens Drug Test Anal 2 589 598 10.1002/dta.211 1:CAS:528:DC%2BC3MXit1Crtw%3D%3D
83. M Thevis A Thomas G Fusshöller S Beuck H Geyer W Schänzer 2010 Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes Rapid Commun Mass Spectrom 24 2245 2254 10.1002/rcm.4637 1:CAS:528: DC%2BC3cXptVajsrc%3D
84. Bogle D (2010) JAAA awaits result of Wilkins drug hearing. In: Jamaica Observer, 14 July 2010. http://www.jamaicaobserver.com/sports/JAAA-awaits- result-of-Wilkins-drugs-hearing-7796590. Accessed 26 Oct 2010
85. Beuck S, Schänzer W, Thevis M (2011) Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes. J Mass Spectrom 46:112-130. doi: 10.1002/jms.1878
86. L Lootens P Van Eenoo P Meuleman OJ Pozo P Van Renterghem G Leroux-Roels FT Delbeke 2009 Steroid metabolism in chimeric mice with humanized liver Drug Test Anal 1 531 537 10.1002/dta.67 1:CAS:528:DC%2BC3cXhtl2hsrw%3D
87. L Lootens P Meuleman OJ Pozo P Van Eenoo G Leroux-Roels FT Delbeke 2009 uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study Clin Chem 55 1783 1793 10.1373/clinchem.2008.119396 1:CAS:528:DC%2BD1MXht1amsbvI
88. L Lootens P Van Eenoo P Meuleman G Leroux-Roels FT Delbeke 2009 The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione Drug Metab Dispos 37 2367 2374 10.1124/dmd.109.028183 1:CAS:528:DC%2BD1MXhsFajtr7I
89. OJ Pozo L Lootens P Van Eenoo K Deventer P Meuleman G Leroux-Roels MK Parr W Schänzer FT Delbeke 2009 Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism Drug Test Anal 1 554 567 10.1002/dta.56 1:CAS:528:DC%2BC3cXhtl2hsr8%3D
90. OJ Pozo P Van Eenoo K Deventer L Lootens S Grimalt JV Sancho F Hernandez P Meuleman G Leroux-Roels FT Delbeke 2009 Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry Steroids 74 837 852 10.1016/j.steroids.2009.05.004 1:CAS:528:DC%2BD1MXptVCitb8%3D
91. OJ Pozo P Van Eenoo K Deventer L Lootens W Van Thuyne MK Parr W Schänzer JV Sancho F Hernandez G Leroux-Roels P Meuleman FT Delbeke 2009 Detection and characterization of a new metabolite of 17a-methyltestosterone Drug Metab Dispos 37 2153 2162 10.1124/dmd.109.028373 1:CAS:528: DC%2BD1MXhtlOqtbbE
92. OJ Pozo W Van Thuyne K Deventer P Van Eenoo FT Delbeke 2008 Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry J Mass Spectrom 43 394 408 10.1002/jms.1343 1:CAS:528:DC%2BD1cXjvVahsL4%3D (Pubitemid 351373939)